Stella Han

821 total citations
25 papers, 685 citations indexed

About

Stella Han is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Stella Han has authored 25 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 6 papers in Physiology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Stella Han's work include Receptor Mechanisms and Signaling (8 papers), Adipose Tissue and Metabolism (6 papers) and Neuropeptides and Animal Physiology (5 papers). Stella Han is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Adipose Tissue and Metabolism (6 papers) and Neuropeptides and Animal Physiology (5 papers). Stella Han collaborates with scholars based in United States, Canada and United Kingdom. Stella Han's co-authors include Abraham Worcel, Andor Udvardy, Arthur Rosenthal, Paul Schedl, Elwood Largis, Baihua Hu, John W. Ellingboe, Fuk‐Wah Sum, Paul Schedl and Michael S. Malamas and has published in prestigious journals such as Cell, Journal of Molecular Biology and Journal of Medicinal Chemistry.

In The Last Decade

Stella Han

24 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stella Han United States 13 536 113 71 66 35 25 685
Esther Allen United States 9 567 1.1× 38 0.3× 51 0.7× 46 0.7× 26 0.7× 13 759
Munehiko Yukioka Japan 16 547 1.0× 30 0.3× 38 0.5× 113 1.7× 49 1.4× 51 688
P G Grant United States 13 475 0.9× 73 0.6× 70 1.0× 57 0.9× 21 0.6× 18 587
Karine Moncoq France 12 560 1.0× 93 0.8× 34 0.5× 70 1.1× 31 0.9× 20 730
Devanand Kowlessur United Kingdom 18 402 0.8× 76 0.7× 34 0.5× 25 0.4× 114 3.3× 30 742
Herbert I. Hadler United States 13 299 0.6× 64 0.6× 34 0.5× 49 0.7× 13 0.4× 40 474
Clive G. Jackson United Kingdom 10 302 0.6× 46 0.4× 29 0.4× 116 1.8× 25 0.7× 16 470
Denis Heissler France 13 595 1.1× 219 1.9× 49 0.7× 26 0.4× 28 0.8× 33 845
K. Ida Japan 13 526 1.0× 35 0.3× 85 1.2× 40 0.6× 38 1.1× 20 630
Roland Van Rapenbusch France 12 482 0.9× 47 0.4× 57 0.8× 29 0.4× 21 0.6× 18 659

Countries citing papers authored by Stella Han

Since Specialization
Citations

This map shows the geographic impact of Stella Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stella Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stella Han more than expected).

Fields of papers citing papers by Stella Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stella Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stella Han. The network helps show where Stella Han may publish in the future.

Co-authorship network of co-authors of Stella Han

This figure shows the co-authorship network connecting the top 25 collaborators of Stella Han. A scholar is included among the top collaborators of Stella Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stella Han. Stella Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cohen, Alexander T., Amol D. Dhamane, Xuejun Liu, et al.. (2024). Effectiveness and Safety of Extended Treatment Apixaban Versus Low-Molecular-Weight Heparin in Cancer-Associated Venous Thromboembolism. Journal of the National Comprehensive Cancer Network. 22(6). 397–403. 1 indexed citations
3.
Lip, Gregory Y.H., Amiee Kang, Xuemei Luo, et al.. (2024). Effectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claims. Journal of Thrombosis and Thrombolysis. 57(6). 1092–1102. 1 indexed citations
4.
Deitelzweig, Steven, Amiee Kang, Jenny Jiang, et al.. (2024). Clinical Impact of Switching or Continuation of Apixaban or Rivaroxaban among Patients with Non-Valvular Atrial Fibrillation. Journal of Clinical Medicine. 13(4). 1073–1073. 2 indexed citations
5.
Zhang, Li, Yu‐Hung Lai, Jenina Capasso, Stella Han, & Alex V. Levin. (2015). Early onset ectopia lentis due to a FBN1 mutation with non‐penetrance. American Journal of Medical Genetics Part A. 167(6). 1365–1368. 11 indexed citations
6.
Sum, Fuk‐Wah, et al.. (2003). Cyclic amine sulfonamides as linkers in the design and synthesis of novel human β3 adrenergic receptor agonists. Bioorganic & Medicinal Chemistry Letters. 13(13). 2191–2194. 18 indexed citations
7.
Steffan, Robert J., et al.. (2002). Novel substituted 4-aminomethylpiperidines as potent and selective human β3-agonists. Part 1: aryloxypropanolaminomethylpiperidines. Bioorganic & Medicinal Chemistry Letters. 12(20). 2957–2961. 8 indexed citations
8.
Steffan, Robert J., et al.. (2002). Novel substituted 4-aminomethylpiperidines as potent and selective human β3-agonists. Part 2: Arylethanolaminomethylpiperidines. Bioorganic & Medicinal Chemistry Letters. 12(20). 2963–2967. 8 indexed citations
9.
Hu, Baihua, et al.. (2001). New oxadiazolidinedione derivatives as potent and selective human β3 agonists. Bioorganic & Medicinal Chemistry Letters. 11(8). 981–984. 18 indexed citations
10.
Ashwell, Mark A., et al.. (2001). 4-Aminopiperidine ureas as potent selective agonists of the human β3-Adrenergic receptor. Bioorganic & Medicinal Chemistry Letters. 11(24). 3123–3127. 14 indexed citations
11.
Hu, Baihua, John W. Ellingboe, Iwan Gunawan, et al.. (2001). 2,4-thiazolidinediones as potent and selective human β3 agonists. Bioorganic & Medicinal Chemistry Letters. 11(6). 757–760. 31 indexed citations
12.
Hu, Baihua, John W. Ellingboe, Stella Han, et al.. (2001). Novel (4-Piperidin-1-yl)-phenyl Sulfonamides as Potent and Selective Human β3 Agonists. Bioorganic & Medicinal Chemistry. 9(8). 2045–2059. 36 indexed citations
13.
Han, Stella, Andor Udvardy, & Paul Schedl. (1985). Neurospora crassa and S1 nuclease cleavage in hsp 83 gene chromatin. Journal of Molecular Biology. 184(4). 657–665. 4 indexed citations
14.
Han, Stella, Andor Udvardy, & Paul Schedl. (1985). Novobiocin blocks the Drosophila heat shock response. Journal of Molecular Biology. 183(1). 13–29. 67 indexed citations
15.
Han, Stella, Andor Udvardy, & Paul Schedl. (1984). Transcriptionally active chromatin is sensitive to Neurospora crassa and S1 nucleases. Journal of Molecular Biology. 179(3). 469–496. 28 indexed citations
16.
Udvardy, Andor, Christos Louis, Stella Han, & Paul Schedl. (1984). Ribosomal RNA genes of Drosophila melanogaster have a novel chromatin structure. Journal of Molecular Biology. 175(2). 113–130. 23 indexed citations
17.
Rosenthal, Arthur & Stella Han. (1969). A Simple Nonchromatographic Determination of Glycerophosphatide in Serum. Clinical Chemistry. 15(3). 197–203. 2 indexed citations
18.
Rosenthal, Arthur & Stella Han. (1969). Phosphorus determination in phosphoglycerides from thin-layer chromatograms. Journal of Lipid Research. 10(2). 243–245. 21 indexed citations
19.
Rosenthal, Arthur, et al.. (1969). Diether phosphinate lecithin: Chemical synthesis and effects on phospholipase C. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 187(3). 385–392. 21 indexed citations
20.
Rosenthal, Arthur & Stella Han. (1968). Effects in vitro and in vivo of synthetic phosphatidate phosphatase inhibitors. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 152(1). 96–103. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esther Allen Breakdown of academic impact, for papers by Munehiko Yukioka Breakdown of academic impact, for papers by P G Grant Breakdown of academic impact, for papers by Karine Moncoq Breakdown of academic impact, for papers by Devanand Kowlessur Breakdown of academic impact, for papers by Herbert I. Hadler Breakdown of academic impact, for papers by Clive G. Jackson Breakdown of academic impact, for papers by Denis Heissler Breakdown of academic impact, for papers by K. Ida Breakdown of academic impact, for papers by Roland Van Rapenbusch
Rankless by CCL
2026